Gene therapy is rapidly reshaping ophthalmic care by targeting the genetic mechanisms responsible for inherited and degenerative eye diseases. Rather than focusing only on symptom management, these approaches aim to restore missing genetic functions or modify disease pathways. The retinal gene therapy market is gaining momentum as the retina offers favorable opportunities for targeted delivery...